Table 1 Frequency (%) and absolute numbers (cells/ μL) of peripheral blood monocyte subsets in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) patients, both at the time of surgical procedure (T0) and once the patients were recovered from surgery (T1), and in healthy individuals (HG). Frequencies of monocyte subsets are related to the total of monocytes

2,4 (1,0-6,6)^a,b

4,9 (2,2-7,0)^a

4,2 (1,5–10)^a,b

5,5 (2,7-9,5)^a

8,2 (5,7–12)

141 (51–330)^a

219 (128–306)^a

329 (135–850)^a

353 (127–733)

503 (285–757)

89 (76–98)

84 (75–92)

89 (41–97)^a

90 (74–96)^a

83 (70–88)

139 (40–287)^a,b

161 (111–282)^a

318 (129–1361)^c

264 (102–601)

393 (171–651)

4,4 (0,3–14)

7,3 (4,8–12)

2,5 (0,5–42)

4,8 (1,7–13)

5,5 (2,8-8,2)

6,1 (0,4–36)^a

15 (8,3–17)^a

12 (0,8–194)

13 (5,8–79)

23 (17–51)

32 (23–83)

44 (33–63)

45 (16–72)^a

38 (23–80)

33 (13–56)

68 (17–77)

56 (37–67)

55 (28–84)^a

62 (20–77)

68 (44–87)

6,0 (0,4-7,5)^a

5,0 (1,1–14)

3,6 (1,0–22)^a

3,5 (0,9–13)^a

11 (5,2–28)

6,7 (0,6–24)^a

6,5 (1,4–24)^a

15 (2,4–60)^a

13 (2,6–58)^a

61 (26–84)